News

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to London's Court of Appeal on Thursday seeking to overturn a prior court ruling ...
Pfizer, BioNTech challenge Moderna’s COVID vaccine patent win in U.K. Jul. 10, 2025 8:08 AM ET Pfizer Inc. (PFE) Stock, MRNA Stock, BNTX Stock By: Dulan Lokuwithana, SA News Editor 1 Comment ...